Friday, May 9, 2025
Weed Deep Dive
  • Politics
  • Lifestyle
  • Business
  • Medical
  • Shop
No Result
View All Result
Weed Deep Dive
  • Politics
  • Lifestyle
  • Business
  • Medical
  • Shop
No Result
View All Result
Weed Deep Dive
No Result
View All Result

Most New York Cannabis Patients Say Cannabis Has Reduced Opoid Usage

Keegan MacDonald by Keegan MacDonald
July 24, 2024
in Featured, Lifestyle
136
SHARES
1.2k
VIEWS
Share on FacebookShare on Twitter
Views: 28

A new report from New York State’s Office of Cannabis Management (OCM) reveals that more than 75% of medical marijuana patients in the state have reduced their intake of prescription drugs due to cannabis use. Notably, 66% of these patients reported a specific reduction in their need for prescription opioids for pain management.

The comprehensive 40-page report draws on surveys conducted last year with current and former medical marijuana patients, as well as medical providers who recommend cannabis. The document covers a range of topics, including qualifying conditions, frequency of use, product types, and patient demographics. It also offers recommendations for enhancing New York’s medical cannabis system.

Despite some challenges, the report indicates general satisfaction among participants in the medical marijuana program. Seventy-nine percent of patients plan to renew their certifications upon expiration, and 86% would recommend the program to friends or family.

To improve the system, the report suggests several measures, including:

– Extending patient certifications from one year to two years.

– Repealing the tax on medical cannabis.

– Allowing patients and caregivers to possess either the Penal Law limits or a 60-day supply of medical cannabis, whichever is greater.

– Removing the two-hour course requirement for providers, allowing the Board to determine necessary training.

– Enacting patient reciprocity to enable out-of-state medical cannabis patients to purchase products in New York.

– Allowing certified patients and caregivers aged 18 and older to cultivate medical cannabis for personal use.

– Requiring coursework on the endocannabinoid system and medical cannabis at NYS higher education institutions, including medical schools.

– Developing policies for faculty at NYS higher education institutions to conduct cannabis research with a NYS Cannabis Research License.

– Supporting insurance companies in covering medical cannabis products.

– Implementing Continuing Medical Education (CME) requirements on medical cannabis for all licensed providers in NYS.

– Continuing to require onsite pharmacists at all medical cannabis dispensaries.

The report highlights that pain management is a primary reason for cannabis use among patients. Sixteen percent of patients use it as an opioid alternative for pain that degrades health and functional capability, and 80% of patients certified under the “other” category have chronic pain alongside another condition. Healthcare providers also noted cannabis’s benefits, with 95% finding it helpful for reducing or treating pain, and 84% indicating improvements in patients’ overall physical functioning.

This report mirrors findings from similar studies, such as a recent review of Ohio’s medical marijuana program, which found that a large majority of patients reported reducing their use of prescription opioids and other drugs due to cannabis.

Overall, the report underscores the positive impact of medical cannabis on reducing reliance on prescription medications, particularly opioids, and offers a roadmap for improving the program to better serve New York’s medical marijuana patients.

Read the whole article here.

Previous Post

Wiz Kahlifa Arrested In Romania After Smoking On Stage

Next Post

DEA Ends Public Comment Period for Rescheduling with 43,000 comments

Keegan MacDonald

Keegan MacDonald

Related Posts

Tariffs And The American Cannabis Industry, How Is It Impacted?

Tariffs And The American Cannabis Industry, How Is It Impacted?

by Keegan MacDonald
May 9, 2025
0

As President Donald Trump’s shifting tariff policies roil global markets, cannabis companies and ancillary businesses across the U.S. are racing...

New Cannabinoid Has Been Discovered

New Cannabinoid Has Been Discovered

by Graham Cooper
May 9, 2025
0

Some researchers in South Korea were searching inside the structure of a cannabis plant for anti-tumor properties when they came...

84% Of Registered Voters In Texas Support Legalizing Cannabis Under Certain Circumstances

84% Of Registered Voters In Texas Support Legalizing Cannabis Under Certain Circumstances

by Keegan MacDonald
May 7, 2025
0

A new University of the Texas Politics Project Poll reveals that a vast majority of Texas voters support the legalization...

California is getting another weed tax hike

California is getting another weed tax hike

by Graham Cooper
May 6, 2025
0

The illicit market continues to thrive, and the main consensus on why that's the case is that taxes on marijuana...

Next Post
DEA Ends Public Comment Period for Rescheduling with 43,000 comments

DEA Ends Public Comment Period for Rescheduling with 43,000 comments

Latest

Tariffs And The American Cannabis Industry, How Is It Impacted?

Tariffs And The American Cannabis Industry, How Is It Impacted?

May 9, 2025
New Cannabinoid Has Been Discovered

New Cannabinoid Has Been Discovered

May 9, 2025
84% Of Registered Voters In Texas Support Legalizing Cannabis Under Certain Circumstances

84% Of Registered Voters In Texas Support Legalizing Cannabis Under Certain Circumstances

May 7, 2025
ADVERTISEMENT
Sign up for the WDD Newsletter

Categories

  • Business
  • Featured
  • Lifestyle
  • Medical
  • Politics
  • Uncategorized

Recent Posts

  • Tariffs And The American Cannabis Industry, How Is It Impacted?
  • New Cannabinoid Has Been Discovered

Browse by Tag

cannabis covid marijuana ban ncaa

AFFILIATES

© Weed Deep DIve. All rights reserved.

No Result
View All Result
  • Politics
  • Business
  • Lifestyle
  • Medical
  • Shop

© Weed Deep DIve. All rights reserved.